Mark Nance
General Counsel bij ENVISTA HOLDINGS CORPORATION
Vermogen: 1 M $ op 29-02-2024
Profiel
Currently, Mark E.
Nance occupies the position of Secretary, Senior Vice President & General Counsel at Envista Holdings Corp.
In his past career he occupied the position of Vice President-Corporate Development at Integrated Nano-Technologies LLC, General Counsel for General Electric Co. and Senior Vice President & Global General Counsel at GE UK Group (a subsidiary of General Electric Co.), Chief Legal Officer & General Counsel at INSYS Therapeutics, Inc., Senior Vice President & Global General Counsel at Mylan NV and Senior Vice President & Global General Counsel at GE Healthcare Medical Diagnostics.
Mr. Nance received a graduate degree from Cornell Law School and an undergraduate degree from the University of Missouri.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
ENVISTA HOLDINGS CORP.
0.03% | 25-02-2024 | 57 972 ( 0.03% ) | 1 M $ | 29-02-2024 |
Actieve functies van Mark Nance
Bedrijven | Functie | Begin |
---|---|---|
ENVISTA HOLDINGS CORPORATION | General Counsel | 01-09-2019 |
Eerdere bekende functies van Mark Nance
Bedrijven | Functie | Einde |
---|---|---|
INSYS THERAPEUTICS, INC. | General Counsel | 31-07-2019 |
Mylan NV
Mylan NV Pharmaceuticals: MajorHealth Technology Mylan NV is a pharmaceutical healthcare company. The firm engages in the development, license, manufacture, market and distribution of generic, branded generic and specialty pharmaceutical products. It operates through the following geographical segments: North America, Europe and Rest of World. The North America segment develops, manufactures, sells, and distributes pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized and cream, or ointment form. The Europe segment operates through subsidiaries in Italy, Germany, the United Kingdom, and Spain. The Rest of World segment comprises of operations in Japan, Australia, China, Brazil, Russia, India, South Africa, Middle East and South East Asia. The company was founded in 1961 and is headquartered in Hatfield, the United Kingdom. | General Counsel | 01-05-2017 |
GE UK Group
GE UK Group MiscellaneousMiscellaneous Part of General Electric Co., GE UK Group is an investment holding private company. The company is based in Altrincham, UK. The British company was founded in 2008. The CEO is Kevin Michael O'Neill. | General Counsel | - |
GE Healthcare Medical Diagnostics | General Counsel | - |
Integrated Nano-Technologies LLC | Corporate Officer/Principal | - |
Opleiding van Mark Nance
University of Missouri | Undergraduate Degree |
Cornell Law School | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
GE AEROSPACE | Producer Manufacturing |
ENVISTA HOLDINGS CORPORATION | Health Technology |
Bedrijven in privébezit | 5 |
---|---|
Integrated Nano-Technologies LLC | Health Technology |
Mylan NV
Mylan NV Pharmaceuticals: MajorHealth Technology Mylan NV is a pharmaceutical healthcare company. The firm engages in the development, license, manufacture, market and distribution of generic, branded generic and specialty pharmaceutical products. It operates through the following geographical segments: North America, Europe and Rest of World. The North America segment develops, manufactures, sells, and distributes pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized and cream, or ointment form. The Europe segment operates through subsidiaries in Italy, Germany, the United Kingdom, and Spain. The Rest of World segment comprises of operations in Japan, Australia, China, Brazil, Russia, India, South Africa, Middle East and South East Asia. The company was founded in 1961 and is headquartered in Hatfield, the United Kingdom. | Health Technology |
GE UK Group
GE UK Group MiscellaneousMiscellaneous Part of General Electric Co., GE UK Group is an investment holding private company. The company is based in Altrincham, UK. The British company was founded in 2008. The CEO is Kevin Michael O'Neill. | Miscellaneous |
GE Healthcare Medical Diagnostics | |
INSYS Therapeutics, Inc.
INSYS Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology INSYS Therapeutics, Inc. operates as a pharmaceutical company, which develops and commercializes supportive care products. It focuses on utilizing commercial pharmaceutical products that include Subsys, a proprietary sublingual fentanyl spray for BTCP in opioid-tolerant adult patients; and Syndros, a proprietary orally administered liquid formulation of dronabinol for the treatment of CINV and anorexia associated with weight loss in patients with AIDS. The company was founded by John N. Kapoor on June 15, 1990 and is headquartered in Chandler, AZ. | Health Technology |